Session 2_ Introduction of NIP .pdf

vf]k lgz'Ns kfOG5 vf]k ;'/lIft x'G5 vf]kn] hLjg /Iff u5{
/fli6«o vf]k sfo{s|dsf]
kl/ro
;];g @

1/30/2023 2
Vff]kaf6 arfpg ;lsg] /f]ux? / hl6ntf
ljkm/ pGd'ng gjlzz' wg':6+sf/ lgjf/0f kf]lnof] pGd'ng glhs

1/30/2023 3
hfklgh OG;]kmnfOl6; bfb'/f

1/30/2023 4
Eofu't] /f]u nx/] vf]sL l;=cf/=P;;

• kl/ro
• vf]k sfo{qmdsf] d'Vo pknlAw / r'gf}tL
• a[xt ax'aifL{o vf]k of]hgf (cMYP) ;g @)!&–@)@! sf
nIo, p2]Zox?
/fli6«o vf]k sfo{qmd

/fli6«o vf]k sfo{qmd (NIP)
•g]kfn ;/sf/sf] k|fyldstf k|fKt sfo{qmd
•hg :jf:Yosf] ;kmn dWo] k|d'v sfo{qmd
•:jf:Yo If]qdf ;j} eGbf nfut k|efjsf/L (Cost
effectiveness)
•afn d[To'b/ 36fpg k|d'v e"ldsf /x]sf]

@))@ : x]kf6fOl6; aL vf]k (Monovalent)
@))$ : l8=lk=l6=–x]k aL vf]k (Tetravalent)
@))* : h]=O{= vf]k -hf]lvdk"0f{ #! lhNnfx?_
@))( : x]df]lkmn; OGkmNo"P~hf aL -l8=lk=l6=,x]k aL, lxj_ (Pentavalent)
@)!# : ?a]nf vf]k -bfb'/f–?a]nf vf]ksf] ?kdf_
@)!$ : topv switch, bopv / cfO{=lk=le= vf]k z'?jft
@)!% : lk=l;=le= vf]k
@)!% M bfb'/f ?j]nf bf];|f] dfqf z'?jft
@)!^ : h]=O{= vf]k -;a} lhNnfx?df lj:tf/_
@)!^÷!& : Pr=lk=le= vf]k -sf:sL / lrtjg lhNnf_
@)!* : Pkm=cfO=kL=eL= vf]k -cfO{=lk=le= vf]k k|lt:yfkg_
@)@) M /f]6f efO{/;sf] vf]k
eflj of]hgf (a[xt ax'aifL{o vf]k of]hgf): HPV, typhoid
Decade of Vaccines
gofF tyf k|of]udf /x]sf vf]kx?sf] lj:tf/

/fli6«o vf]k sfo{qmd (NIP)
• nlIft ;d'x M !% dlxgf d'lgsf afnaflnsfx?
• !@ j6f Antigen x? af6 M -d'Vo arfpg] /f]ux? Ifo/f]u, /f]6f,
kf]lnof]dfOnfO{l6;, Go"df]lgof, d]lgGhfO{6L;, Eofu't]/f]u, nx/]vf]sL,
x]kf6fO{6L; aL, wg'i6+sf/, bfb'/f, ?a]nf, / hfkflgh OG;]kmnfOl6;_
la?2sf vf]kx? lbO{G5 .
• ue{jtL dlxnfx? M ue{jtL dlxnfx?sf nflu 6L=8L=-Td_ -wg'i6+sf/ /
Eofu't] /f]u la?4_
gf]6 M vf]k ;]jf dfl;s b]ze/sf !^,))) eGbf w]/} vf]k s]Gb| / !&)))
eGbf w]/} vf]k ;];gx? sf ;fy} lghL tyf u}/;/sf/L :jf:Yo ;+:yfx?
Dffkm{t k|bfg ul/Fb} cfPsf] 5 .

vf]k ;]jf ;~rfng
;+:yfut vf]ks]Gb| (Fixed Session) : k|To]s dlxgf, k|To]s :jf:Yo ;+:yfdf
afXo vf]k s]Gb| (Out Reach Sessions) : k|To]s dlxgf, ;fljssf uf=lj=;=x?sf] j8fx?df slDtdf #
b]lv % j6f s]Gb|af6
3'DtL vf]k s]Gb| (Mobile clinics) : uf=kf=, g=kf=sf] :jf:Yo ;+:yfsf] ks8If]q leq /x]sf kx'Fraf6 6f9f
ePsf jl:t, ;d'bfo / ef}uf]lns If]qdf slDtdf jif{sf] $ k6s vf]k s]Gb| :yfkgf u/L vf]k ;]jf k|bfg
ul/Psf]
Gff]6 M vf]k s]Gb|x?sf] of]hgf ubf{ t/fO{df cfwf b]lv ! 306f leq tyf kxf8 / lxdfnL If]qdf a9Ldf !
306f #) ldg]6 leqsf] b'/Ldf vf]k s]Gb| :yfkgf ug'{kb{5 . xfnsf] gof+ ;+/rgf cg';f/ ;j} :yflgo
txx?df vf]ksfo{qmdsf] ;'Idof]hgf tof/L Pj+ vf]k;];g k'gof]{hgf ug'{ kb{5 .

b'/b[li6 (Vision)
g]kfndf vf]kaf6 arfpg ;lsg] /f]ux¿nfO{ z'Go cj:yfdf k'¥ofpg]] .
Wo]o (Mission)
/fli6«o vf]k sfo{qmd dfk{mt tf]lsPsf ;a} vf]kx¿ ;dtfd'ns ?kdf ;a} sf]
kx'+rdf x'g] u/L k|To]s afnaflnsf / ue{jtL dlxnfnfO{ u'0f:tl/o, ;'/lIft /
;j{;'ne vf]k ;]jf lg/Gt/ ?kdf k|bfg ug{] .
vf]k sfo{qmdsf] nIo (Goal)
vf]kaf6 arfpg ;lsg] /f]uf0f' b/, ckfËtf / d[To'b/nfO{ sd ug'{ g} vf]k
sfo{qmdsf] k|d'v nIo xf] .
a[xt ax'aifL{o vf]k of]hgf (cMYP) ;g @)!&–@)@!

/fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf på]Zox?
• vf]kaf6 arfpg ;lsg] /f]ux?sf] lgoGq0f, lgjf/0f / pGd'ngnfO{ ltj|tf lbO{ ;f] sf] lbuf]kg sfod /fVg]
✓kf]lnof] z'Go cj:yf sfod ug]{ -;g @)!)_
✓gjlzz' wg'i6‹f/ lgjf/0f sfod /fVg] -;g @))%_
✓bfb'/f lgjf/0f ug]{ -;g @)@#_
✓x]kf6fO{6L; aL, h]=O{, afnaflnsfdf x'g] hl6n k|sf/sf] Ifo/f]u nufot cGo /f]ux? lgoGq0f u/L
sfod /fVg]
• k|To]s afnafnLsfn] k"0f{ vf]k nufPsf] ;'lglZrt ug]{
• ;a} vf]kx?sf] se/]h ;a} txdf (% k|ltzt eGbf dfyL k'¥ofO{ ;f] sfod /fVg]

/fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf på]Zox?
•vf]k sf]N8r]g cfk"lt{ Aoj:yfkg ;'b[9 u/L u'0f:t/Lo vf]k ;]jfsf] ;'lglZrttf /
kmf]x/d}nfsf] plrt Aoj:yfkg ug]{,
•gofF tyf sd k|of]u ePsf vf]kx? ;dfj]z u/L vf]kaf6 hf]ufpg ;lsg] /f]ux?sf]
lgoGq0fnfO{ cem} a9fjf lbg],
•vf]kaf6 arfpg ;lsg] /f]ux?sf] vf]hk8tfn -;le{n]G;_ sfo{nfO{ lj:tf/ ug]{ .

• lakm/ /f]usf] pGd"ng
• afn d[To'b/ df pNn]Vo sld -;x;|flAb nIf $ / % k|fKt_
• ;g @))% b]lv dft[ tyf gjlzz' wg'i6Íf/ /f]u lgjf/0f
• ;g @)!) b]lv kf]lnof] /f]u z"Go cj:yf / pGd"ngsf] glhs
• hfkflgh O{G;]kmnfO{l6; /f]u lgoGq0f
• ;g @)!* b]lv ?a]nf tyf l;=cf/=P; (Congenital Rubella Syndrome) lgoGq0f
• bfb'/f ?a]nf /f]u lgjf/0ftkm{ pGd"v
• Affnaflnsfdf æx]kf6fO{l6; laÆ lgoGq0f -;g @)!(_
• vf]k4f/f arfpg ;lsg] cGo /f]ux¿df pNn]vgLo sdL
• k"0f{ vf]k ;'lglZrttf 3f]if0ff
• vf]k P]g / lgodfjnL hf/L
vf]k sfo{qmdsf] d"Vo pknlAwx¿
;g @)!* df Rubella and CRS
lgoGq0f k|df0fLs/0f, WHO-
SEARO af6 k|fKt

/fli6«o vf]k sfo{qmd / nIo -ax'jlif{o vf]k of]hgf / lbuf] ljsf; nIo_
k|fKt pknlJwx? sfod /fVb} -;Dj[l4sf] / lbuf] lasf; nIf k|flKtsf nflu_
• afn tyf dft[ d[To' b/df sld Nofpg]
• cf}ift cfo'df jl[4
• /f]ux? pGd'ng ug]{ – kf]lnof] ;g @)@#
• /f]ux? lgjf/0f ug]{
• dft[ tyf gjlzz' wg'i6+sf/sf] lgjf/0f -;g @))% b]lv _ sfod /fVg]
• bfb'/f ?j]nf lgjf/0f -;g @)@# _
• /f]ux? lgoGq0f ug]{
• x]kf6fO{6L; aL, h]=O{, l6=jL cflb lgoGq0f / sfod ug]{
• k"0f{vf]k z'lglZrttf / lbuf]kgf -k"0f{vf]k o'Qm b]z 3f]if0ff ug]{_
nIo k|flKt, vf]k
sfo{qmdsf] ljsf;,
lj:tf/ /
Joj:yfkgsf] nfuL
ax'alif{o vf]k of]hgf
@)!&-@!

/fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf
på]Zox?
• u'0f:t/Lo vf]k ;]jfsf] nfuL cfk'tL{ Aoj:yf tyf vf]k sf]N8r]g
Joj:yfkgsf] ;'99Ls/0f ug]{
• goFf tyf sd k|of]u ePsf vf]kx? ;dfj]z u/L vf]kaf6 hf]ufpg ;lsg]
/f]ux?sf] lgoGq0fnfO{ cem} a9fjf lbg]
• vf]kaf6 arfpg ;lsg] /f]ux?sf] vf]hk8tfn -;le{n]G;_ sfo{nfO{ lj:tf/
ug]{
• ! aif{ eGbf dflysf] pd]/ ;d'xsf] nfuL vf]k ;]jf lj:tf/ ub}{ n}hfg]
• vf]k sfo{qmdsf] Aoj:yfkgdf gljgtd k|ljlw, cg';Gwfg / ;fdflhs
kl/rfngdf a9fjf lbg] ;fy} lbuf] ljlQo Aoj:yfkg ;'lglZrt ug]{

lgoldt vf]k sfo{qmdsf r'gf}tLx?
NDHS @)!^
@! Ü afnaflnsf k"0f{ vf]kaf6 al~rt 5g eg] ! Ü jRrf z'Go 8f]hdf 5g .
78%
21%
1%
vf]k se/]hsf] cj:yf k"0f{ vf]k
cf+lzs vf]k
z'Go 8f]h

g]kfnsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
92
82 82
88
85
80 79 81
66
91
86 84
88 86
81 81
84
73
86
78 77
85
81
78 78 80
70
0
10
20
30
40
50
60
70
80
90
100
BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77

90
82 82
86 85 83
79
82
69
87
83 81
85 83
80
84
81
75
82
74 74
80
76 75 77 79
71
0
10
20
30
40
50
60
70
80
90
100
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
k|b]z g+ ! sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

104
87 89
101
94
80
72
85
58
107 105
97
108
104
89
82
95
71
97
90
87
103
97
86
79
89
66
0
20
40
60
80
100
120
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
k|b]z g+ @ sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

84
73 73 75 75
72
75 74
57
81
72 71 73 72 72
69
73
60
82
68 68
72 71 69 69 70
61
0
10
20
30
40
50
60
70
80
90
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
afudtL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

73 72 72
75 74
71
83
71 70
72 74 74 76 75 74
80
74
77
66
69 69 71 70 70
78
70
75
0
10
20
30
40
50
60
70
80
90
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
u08sL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

98
87 87
91 90
85
90
86
79
98
90
87
94
91
87 89 88
84
92
81 81
89
85 84 86 85
80
0
20
40
60
80
100
120
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
k|b]z g+ % sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

106
93 94
102
97
90
86
95
73
102 99 97 98 96
89 86
94
78
93
89 86
94
90
86 86
90
77
0
20
40
60
80
100
120
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
s0ff{nL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

87
83 83
87
84 84
79
82
70
84 82 82 83 82 80 81
84
75
81
75 75
80
77 77
80 78
75
0
10
20
30
40
50
60
70
80
90
100
ChartTitle
FY 2074/75 FY 2075/76 FY 2076/77
;'b'/klZrd k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf

lgoldt vf]k sfo{qmdsf d"Vo r'gf}lt / cj;/x?
NDHS @)!^
@! Ü afnaflnsf k"0f{ vf]kaf6 al~rt 5g eg] ! Ü jRrf z'Go 8f]h
!= sl/j (( k|ltzt aRrfx?n] klxnf] vf]k z'? u/]tf klg pd]/ a9b} hf+bf kl5sf vf]kx?sf] dfqf lng 5'6
x'g] u/]sf]
@= vf]k z'? u/]sf aRrfx? dWo sl/j @! k|ltzt afnaflnsfx? 8«kcfp6 eO{ &* k|ltzt dfq
afnaflnsfx?n] k"0f{vf]k lnPsf]
#= bfb'/f ?j]nfsf] bf];|f] dfqfsf] se/]h clt Go"g /x]sf]
$= cem} ! k|ltzt Affnaflnsfx? s'g} klg vf]k gkfPsf] cj:yfdf /x]sf] -z'Go 8f]h_

 != /f]u lgoGq0f, lgjf/0f / pGd"ng ug{ vf]k ;]jf k|bfg ul/Psf] xf] .
 @. cem}klg @@ k|ltzt aRrfx? k""0f{ vf]k kfpgaf6 alGrt 5g .
 #= k|To]s dlxgf vf]k ;]jf k|bfg u/] kZrft vf]k k|fKt u/]sf / 5'6 ePsf aRRffsf] klxrfg ul/ vf]k
lbnfpg' k5{ .
 $. ;a} aRrfnfO{ k"0f{ vf]k lbnfpg' :jf:Yosld{sf] bfloTj xf] .
;f/f+z

Session 2_ Introduction of NIP .pdf

More Related Content

More from Public Health Concern Nepal

Recently uploaded

Session 2_ Introduction of NIP .pdf